Caricamento...
Feasibility of a pilot program for COVID‐19 convalescent plasma collection in Wuhan, China
BACKGROUND: A novel coronavirus has caused an international outbreak. Currently, there are no specific therapeutic agents for coronavirus infections. Convalescent plasma (CP) therapy is a potentially effective treatment option. METHODS: Patients who had recovered from COVID‐19 and had been discharge...
Salvato in:
| Pubblicato in: | Transfusion |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300543/ https://ncbi.nlm.nih.gov/pubmed/32491199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15921 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|